Biocryst Pharmaceuticals's top three insider shareholders as of March 23, 2026 are Jon P Stonehouse (Director, 1.32Mn shares), Charles K Gayer (President And Cco, 952.58K shares), Alane P Barnes (Chief Legal Officer, 398.75K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jon P Stonehouse | 1,323,850 | 0 | 03 Mar, 2026 | |
| Charles K Gayer | President And Cco | 952,583 | 0 | 23 Dec, 2025 |
| Alane P Barnes | Chief Legal Officer | 400,703 | 0 | 18 Mar, 2026 |
| Anthony Doyle | Chief Financial Officer | 377,867 | 0 | 23 Dec, 2024 |
| Helen M. Thackray | Chief Rd Officer | 377,318 | 0 | 02 Apr, 2025 |
| Yarlagadda S Babu | Chief Discovery Officer | 298,541 | 0 | 16 Nov, 2022 |
| Babar Ghias | Chief Financial Officer | 268,700 | 0 | 19 Dec, 2025 |
| Robert Alexander Ingram | 100,198 | 0 | 02 Mar, 2023 | |
| Nancy J Hutson | 99,138 | 0 | 16 Jun, 2025 | |
| Vincent Milano | 92,067 | 0 | 03 Mar, 2026 | |
| Kenneth B Jr Lee | 68,863 | 0 | 15 Jun, 2023 | |
| Theresa Heggie | 65,352 | 0 | 15 Aug, 2025 | |
| Alan G Levin | 64,271 | 0 | 16 Jun, 2025 | |
| Amy E Mckee | 42,432 | 0 | 03 Mar, 2026 | |
| Jon P Stonehouse | Chief Executive Officer | 0 | 40,000 | 19 Dec, 2025 |
| William P Sheridan | Chief Medical Officer | 37,954 | 0 | 14 Mar, 2022 |
| Machelle Sanders | 30,642 | 0 | 17 Nov, 2025 | |
| Steven K Galson | 24,991 | 0 | 16 Jun, 2025 | |
| Steven Frank | 18,903 | 0 | 03 Mar, 2026 | |
| Michael L Jones | Exec. Director, Finance Pao | 16,653 | 0 | 21 Dec, 2022 |
| Jill C. Milne | 15,382 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Alane P Barnes | Common Stock | A | 150,000 | $5.51 | 550,703 | D | M |
| 16 Mar, 2026 | Alane P Barnes | Common Stock | D | 150,000 | $9.15 | 400,703 | D | S |
| 16 Mar, 2026 | Alane P Barnes | Emp. Stock Option (Right to Buy) | D | 150,000 | $0.00 | 0 | D | M |
| 27 Feb, 2026 | Steven Frank | Common Stock | A | 1,285 | $8.75 | 18,903 | D | A |
| 27 Feb, 2026 | Amy E Mckee | Common Stock | A | 642 | $8.75 | 42,432 | D | A |
| 27 Feb, 2026 | Jon P Stonehouse | Common Stock | A | 421 | $8.75 | 1,323,850 | D | A |
| 27 Feb, 2026 | Jill C. Milne | Common Stock | A | 528 | $8.75 | 15,382 | D | A |
| 27 Feb, 2026 | Vincent Milano | Common Stock | A | 848 | $8.75 | 92,067 | D | A |
| 02 Mar, 2026 | Jon P Stonehouse | Common Stock | A | 305,995 | $3.22 | 1,629,845 | D | M |
| 02 Mar, 2026 | Jon P Stonehouse | Common Stock | D | 305,995 | $8.64 | 1,323,850 | D | D |
| 02 Mar, 2026 | Jon P Stonehouse | Emp. Stock Option (Right to Buy) | D | 305,995 | $0.00 | 0 | D | M |
| 23 Jan, 2026 | Jill C. Milne | Common Stock | A | 2,582 | - | 2,582 | D | A |
| 23 Jan, 2026 | Jill C. Milne | Common Stock | A | 12,272 | $0.00 | 14,854 | D | A |
| 23 Jan, 2026 | Jill C. Milne | Automatic Stock Option Grant | A | 26,684 | $0.00 | 26,684 | D | A |
| 19 Dec, 2025 | Alane P Barnes | Common Stock | D | 16,902 | $7.41 | 420,524 | D | F |
| 19 Dec, 2025 | Charles K Gayer | Common Stock | D | 11,477 | $7.41 | 878,350 | D | F |
| 19 Dec, 2025 | Jon P Stonehouse | Common Stock | D | 61,793 | $7.41 | 1,323,429 | D | F |
| 22 Dec, 2025 | Charles K Gayer | Common Stock | A | 14,142 | $3.22 | 892,492 | D | M |
| 22 Dec, 2025 | Alane P Barnes | Common Stock | D | 21,773 | $7.65 | 398,751 | D | S |
| 22 Dec, 2025 | Charles K Gayer | Common Stock | A | 10,091 | $5.04 | 902,583 | D | M |